Notes
Slide Show
Outline
1
Mortality rates,
by modality
Figure 6.1
2
Adjusted admissions & days,
by modality
Figure 6.2
3
Geographic variations in adjusted hospital admissions per patient year, by HSA:
all patients, 2004
Figure 6.3
4
Geographic variations in adjusted hospital admissions per patient year, by HSA: hemodialysis, 2004
Figure 6.3 (continued)
5
Geographic variations in adjusted hospital admissions per patient year, by state:
peritoneal dialysis, 2004
Figure 6.3 (continued)
6
Geographic variations in adjusted hospital admissions per patient year, by state:
transplant, 2004
Figure 6.3 (continued)
7
Change in hospital admissions
since 1993
Figure 6.4
8
Adjusted admissions for
principal diagnoses, by modality
Figure 6.5
9
Percent change in adjusted hospitalization rates for prevalent dialysis patients, 1995–2004, by demographic characteristics & primary diagnosis
Figure 6.6
10
Adjusted hospitalization rates,
by vintage: hemodialysis
Table 6.a
11
Adjusted hospitalization rates,
by vintage: peritoneal dialysis
Table 6.b
12
Adjusted hospitalization rates,
by vintage: transplant
Table 6.c
13
Adjusted cause-specific
hospital admissions, by age
Figure 6.7
14
Adjusted admissions with cardiovascular procedures, by age
Figure 6.8
15
Adjusted inpatient vascular access procedures, by age
Figure 6.9
16
Geographic variations in cause-specific admissions per patient year, 2004: hemodialysis, cardiovascular disease
Figure 6.10
17
Geographic variations in cause-specific admissions per patient year, 2004:
hemodialysis, infection
Figure 6.10 (continued)
18
Geographic variations in cause-specific admissions per patient year, 2004: hemodialysis, vascular access
Figure 6.10 (continued)
19
Geographic variations in cause-specific admissions per patient year, 2004:
peritoneal dialysis, cardiovascular disease
Figure 6.10 (continued)
20
Geographic variations in cause-specific admissions per patient year, 2004:
peritoneal dialysis, infection
Figure 6.10 (continued)
21
Geographic variations in cause-specific admissions per patient year, 2004:
transplant, cardiovascular
Figure 6.10 (continued)
22
Geographic variations in cause-specific admissions per patient year, 2004: transplant, infection
Figure 6.10 (continued)
23
Geographic variations in cause-specific admissions per patient year, 2004:
all patients, cardiovascular disease
Figure 6.10 (continued)
24
Geographic variations in cause-specific admissions per patient year, 2004:
all patients, infection
Figure 6.10 (continued)
25
Percent change in catheter insertion rates, 1994 to 2004, by state
Figure 6.11
26
Percent change in infectious admission rates, by state, 1994 to 2004
Figure 6.11 (continued)
27
All-cause mortality rates,
by age, 2004
Figure 6.12
28
Geographic variations in all-cause mortality in the ESRD population, 2004
Figure 6.13
29
Geographic variations in all-cause mortality in the dialysis population, 2004
Figure 6.13 (continued)
30
Geographic variations in all-cause mortality in the transplant population, 2004
Figure 6.13 (continued)
31
Geographic variations in all-cause mortality in the general population age 65+, 2004
Figure 6.13 (continued)
32
Expected remaining lifetimes (years)
of the general U.S. population,
by age, gender, & race
Table 6.d
33
Adjusted mortality rates,
by vintage
Figure 6.14
34
All-cause mortality: patients with major diseases, 2004
Figure 6.15
35
Adjusted five-year survival,
by modality & primary diagnosis:
1990-1994
Figure 6.16
36
Adjusted five-year survival,
by modality & primary diagnosis:
1995-1999
Figure 6.16 (continued)
37
Survival rates after major disease diagnosis in the ESRD & general populations
Figure 6.17
38
Adjusted cause-specific mortality,
by age
Figure 6.18
39
Adjusted mortality:
heart disease
Figure 6.19
40
Adjusted mortality:
cerebrovascular disease
Figure 6.20
41
Adjusted mortality:
septicemia
Figure 6.21
42
Geographic variations in cause-specific mortality per patient year, by state, 2004: dialysis, heart disease
Figure 6.22
43
Geographic variations in cause-specific mortality per patient year, by state, 2004: dialysis, cardiovascular disease
Figure 6.22 (continued)
44
Geographic variations in cause-specific mortality per patient year, by state, 2004: dialysis, septicemia
Figure 6.22 (continued)
45
Geographic variations in cause-specific mortality per patient year, by state, 2004: transplant, heart disease
Figure 6.22 (continued)
46
Geographic variations in cause-specific mortality per patient year, by state, 2004: transplant, cardiovascular disease
Figure 6.22 (continued)
47
Geographic variations in cause-specific mortality per patient year, by state, 2004: transplant, septicemia
Figure 6.22 (continued)
48
Geographic variations in cause-specific mortality per patient year, by state, 2004:
all patients, heart disease
Figure 6.22 (continued)
49
Geographic variations in cause-specific mortality per patient year, by state, 2004:
all patients, cardiovascular disease
Figure 6.22 (continued)
50
Geographic variations in cause-specific mortality per patient year, by state, 2004:
all patients, septicemia
Figure 6.22 (continued)
51
Percent change in cause-specific mortality rates, 1994 to 2004: heart disease
Figure 6.23
52
Percent change in cause-specific mortality rates, 1994 to 2004: cerebrovascular disease
Figure 6.23
53
Percent change in cause-specific mortality rates, 1994 to 2004: septicemia
Figure 6.23
54
Rate of incident CVA/TIA,
by age
Figure 6.24
55
Time to hospitalization
following incident CVA
Figure 6.25
56
Survival rates
following incident CVA
Figure 6.26
57
Time to hospitalization
following incident TIA
Figure 6.27
58
Survival rates
following incident TIA
Figure 6.28
59
Rate of prevalent CVA,
by age
Figure 6.29
60
Rate of prevalent TIA,
by age
Figure 6.30
61
Rate of incident CVA
in prevalent patients, by age
Figure 6.31
62
Rate of incident TIA
in prevalent patients, by age
Figure 6.32
63
Time to hospitalization following
peripheral neuropathy diagnosis
Figure 6.33
64
Survival following
peripheral neuropathy diagnosis
Figure 6.34
65
Time to hospitalization following peripheral neuropathy diagnosis: diabetic patients
Figure 6.35
66
Survival rates following peripheral neuropathy diagnosis: diabetic patients
Figure 6.36
67
Time to hospitalization following peripheral neuropathy diagnosis: non-diabetic patients
Figure 6.37
68
Survival rates following peripheral neuropathy diagnosis: non-diabetic patients
Figure 6.38
69
Rate of peripheral neuropathy, by age,
race, & diabetic status: incident patients
Figure 6.39
70
Rate of peripheral neuropathy, by age,
race, & diabetic status: prevalent patients
Figure 6.40
71
Time to hospitalization with or without a peripheral neuropathy diagnosis
Figure 6.41
72
Survival with or without
a peripheral neuropathy diagnosis
Figure 6.42
73
Prevalent dementia in prevalent
patients: occurrence of dementia,
by age & time period
Figure 6.43
74
Prevalent dementia in prevalent
patients: occurrence of dementia,
by age & type of dementia
Figure 6.44
75
Event-free probability of hospitalization
in patients with or without dementia
Figure 6.45
76
Survival probability in patients
with or without dementia
Figure 6.46
77
Incident (new) dementia in prevalent patients: first diagnosis of dementia,
by age & time period
Figure 6.47
78
Incident (new) dementia in prevalent patients: first diagnosis of dementia,
by dementia type
Figure 6.48
79
Hazard ratios of incident dementia
Table 6.e